Search

everythinglearnresearchcommunity

for

Search:↓

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Using only hyperandrogenism to diagnose PCOS can lead to overdiagnosis.

Baicalin may help reduce excessive male hormone levels in PCOS.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

Healthy diet and exercise are important for women with PCOS to manage weight and metabolic issues, and supplements like omega-3, vitamin D, and inositol may help.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Many men with male pattern baldness have abnormal blood fat levels, which may raise their risk of heart disease.

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.

Myo-inositol plus α-lactalbumin works better than myo-inositol alone for improving symptoms of PCOS.

Hispanic women with PCOS are more likely to have liver diseases like NAFLD and NASH.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Resistance training improved BMI and menstrual regularity more in women with PCOS than aerobic training.

PCOS may be influenced by factors in the blood, not just the ovaries.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.